RU97102453A - QUANTODEPRESSANT MEANS FOR TREATING ONCOLOGICAL DISEASES OF THE LUNGS, Larynx, Thyroid, MAMMARY AND OTHER BREAST CELLS AND METHOD OF TREATMENT - Google Patents
QUANTODEPRESSANT MEANS FOR TREATING ONCOLOGICAL DISEASES OF THE LUNGS, Larynx, Thyroid, MAMMARY AND OTHER BREAST CELLS AND METHOD OF TREATMENTInfo
- Publication number
- RU97102453A RU97102453A RU97102453/14A RU97102453A RU97102453A RU 97102453 A RU97102453 A RU 97102453A RU 97102453/14 A RU97102453/14 A RU 97102453/14A RU 97102453 A RU97102453 A RU 97102453A RU 97102453 A RU97102453 A RU 97102453A
- Authority
- RU
- Russia
- Prior art keywords
- iodine
- larynx
- treatment
- lungs
- thyroid
- Prior art date
Links
- 210000000867 Larynx Anatomy 0.000 title claims 5
- 210000001685 Thyroid Gland Anatomy 0.000 title claims 5
- 210000004072 Lung Anatomy 0.000 title claims 4
- 201000010099 disease Diseases 0.000 title claims 3
- 230000000771 oncological Effects 0.000 title claims 3
- 210000000481 Breast Anatomy 0.000 title 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 9
- 229910052740 iodine Inorganic materials 0.000 claims 9
- 239000011630 iodine Substances 0.000 claims 9
- XMBWDFGMSWQBCA-OUBTZVSYSA-N iodane Chemical compound [128IH] XMBWDFGMSWQBCA-OUBTZVSYSA-N 0.000 claims 5
- 210000002264 Mammary Glands, Animal Anatomy 0.000 claims 4
- 210000004293 Mammary Glands, Human Anatomy 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drugs Drugs 0.000 claims 3
- 229940044173 Iodine-125 Drugs 0.000 claims 2
- 210000000038 chest Anatomy 0.000 claims 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 2
- XMBWDFGMSWQBCA-BJUDXGSMSA-N iodane Chemical compound [126IH] XMBWDFGMSWQBCA-BJUDXGSMSA-N 0.000 claims 2
- XMBWDFGMSWQBCA-OIOBTWANSA-N iodane Chemical compound [124IH] XMBWDFGMSWQBCA-OIOBTWANSA-N 0.000 claims 2
- ZCYVEMRRCGMTRW-AHCXROLUSA-N iodine-123 Chemical compound [123I] ZCYVEMRRCGMTRW-AHCXROLUSA-N 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 210000000056 organs Anatomy 0.000 claims 2
- -1 moreover Chemical compound 0.000 claims 1
- 210000004369 Blood Anatomy 0.000 claims 1
- 210000004080 Milk Anatomy 0.000 claims 1
- 210000003928 Nasal Cavity Anatomy 0.000 claims 1
- 210000003800 Pharynx Anatomy 0.000 claims 1
- 229940098465 Tincture Drugs 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
Claims (2)
йод-123 0,002 - 0,003 г с 5% добавкой йода-128,
йод-124 0,003 - 0,004 г с 5% добавкой йода-128,
йод-125 0,001 - 0,002 г с 5% добавкой йода-128,
йод-126 0,001 - 0,004 г с 5% добавкой йода-128,
причем йод-128 самостоятельно не применяется, а смесь радионуклидов йода 123, 124, 125, 126 0,001 - 0,002 г с 5% добавкой йода - 128.1. Quantum-depressant drug for the treatment of oncological diseases of the lungs, larynx, thyroid gland, mammary gland and other organs of the chest, containing an active principle, characterized in that iodine radionuclides - 123, 124, 125, 126, 128 are used as the active principle in the following weight quantities:
iodine-123 0.002 - 0.003 g with 5% addition of iodine-128,
iodine-124 0.003 - 0.004 g with 5% addition of iodine-128,
iodine-125 0.001 - 0.002 g with 5% addition of iodine-128,
iodine-126 0.001 - 0.004 g with 5% addition of iodine-128,
moreover, iodine-128 is not independently used, and a mixture of iodine radionuclides 123, 124, 125, 126 0.001 - 0.002 g with 5% iodine supplement - 128.
а) лечении гортани, щитовидной железы, молочной железы готовят квантодепрессантную, мягкую, сухую, пластырную повязку, с внутренней стороны которой наносят йод в количестве 0,001 - 0,005 г и накладывают на пораженные онкологическими заболеваниями места с внешней стороны на срок:
йод - 123 7 - 8 суток,
йод - 124 25 - 30 суток,
йод - 125 1 - 5 месяцев,
йод - 126 6 - 7 недель,
смесь радионуклидов 30 - 40 суток,
б) лечении гортани подают йод пульверизацией в полости носа и глотки в количестве указанных доз за 3-4 раза в неделю,
в) лечении щитовидной железы, молочной железы подают йод в пределах указанных доз внутривенной инъекцией в кровь за 2-3 инъекции в течение недели,
г) лечении гортани, щитовидной железы, молочной железы и других органов грудной клетки подают йод в виде спиртового 5% раствора по 3-4 капли настойки 1/4 стакана кипяченого молока после еды в течение недели,
д) лечении легких в пределах указанных доз подают йод в смеси с воздухом в качестве ингаляции внутрь легких при 30 - 36oC2. A method of treating cancer, including the use of drugs, characterized in that the drugs used are the iodine radionuclide according to claim 1, with
a) treating the larynx, thyroid gland, and mammary gland, a quantum-depressant, soft, dry, patch bandage is prepared, on the inside of which iodine is applied in an amount of 0.001-0.005 g and applied to places affected by oncological diseases from the outside for a period of:
iodine - 123 7 - 8 days,
iodine - 124 25-30 days,
iodine - 125 1 - 5 months,
iodine - 126 6 - 7 weeks,
a mixture of radionuclides 30 to 40 days,
b) treating the larynx with iodine by spraying in the nasal cavity and pharynx in the amount of the indicated doses 3-4 times a week,
c) treatment of the thyroid gland, mammary gland serves iodine within the indicated doses by intravenous injection into the blood for 2-3 injections within a week,
g) the treatment of the larynx, thyroid gland, mammary gland and other organs of the chest serves iodine in the form of an alcohol 5% solution of 3-4 drops of tincture 1/4 cup boiled milk after eating for a week,
d) treatment of the lungs within the specified doses serves iodine mixed with air as an inhalation into the lungs at 30 - 36 o C
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU97102453A true RU97102453A (en) | 1999-02-27 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4193985A (en) | Multiple-units drug dose | |
| SE9401406L (en) | Pharmaceutical products for the cure of tumor diseases as well as a method for the preparation thereof | |
| ES8403321A1 (en) | Fibrinogen preparation, process for its manufacture and use thereof. | |
| ATE94393T1 (en) | DOSE FORM FOR ORAL ADMINISTRATION OF HYPOGLYCAEMIC GLIPICIDE. | |
| ES2116986T3 (en) | METAL-PEPTIDE COMPOSITIONS AND COSMETIC METHODS TO STIMULATE HAIR GROWTH. | |
| ATE138562T1 (en) | TRANSMUCOSAL DOSAGE FORM | |
| AU723812B2 (en) | Medicinal preparation and a method of medicinal action on human organism | |
| ES478967A1 (en) | 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds | |
| RU99118588A (en) | A NEW MEDICINE FOR INHALATION, HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML, CONTAINING FORMOTEROL | |
| DE58901002D1 (en) | AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES. | |
| Dun | Veterinary Medicines Their Actions and Uses | |
| RU99118586A (en) | A NEW MEDICINE FOR INHALATION HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML, CONTAINING TERBUTALINE SULFATE, METHOD FOR PRODUCING AND ITS APPLICATION | |
| DK407287D0 (en) | MULTIGRANULTABLE WITH DELAYED DELIVERY | |
| RU97102453A (en) | QUANTODEPRESSANT MEANS FOR TREATING ONCOLOGICAL DISEASES OF THE LUNGS, Larynx, Thyroid, MAMMARY AND OTHER BREAST CELLS AND METHOD OF TREATMENT | |
| CN109498599A (en) | Daily health caring sustained-release gel ointment table | |
| KR100271087B1 (en) | Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia | |
| SU1469826A1 (en) | Copolymer of l-lysine and l-glutamic acid containing side groups and showing prolonged hypotensive activity and compensatory effect at hemorrhagic shock, and a method of its preparing | |
| RU93031184A (en) | DRUG FOR PREVENTION AND TREATMENT OF BIRD DISEASES | |
| ATE66375T1 (en) | USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES. | |
| RU2142267C1 (en) | Method for treating oral cavity mucosa candidiasis | |
| GB2198351B (en) | Improvements in or relating to the use of epidermal growth factor for enhancing the uptake of iron in vivo. | |
| Gillette et al. | Response of the Neonatal Heart to a New Inotropic Agent, RO2-2985 (X537A) | |
| SU1157558A1 (en) | Method of simulating hyperplasia of tunic cells | |
| RU2164132C2 (en) | Suppository with radon of medical designation | |
| US2768113A (en) | Therapeutic composition of procaine and adrenaline precursor |